ADMP Insider Trading Activity and SEC Form 4 Filings
ADMP insider trading summary
No open-market insider purchases or sales of Adamis Pharmaceuticals Corp (ADMP) have been reported on SEC Form 4 in the past 12 months.
Latest ADMP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 18, 2022 | David J. Marguglio | SVP and Chief Business Officer | Sell | $7K (11,859 @ $0.60) |
| Mar 18, 2022 | Dennis J Phd Carlo | President & CEO | Sell | $6K (10,490 @ $0.60) |
| Mar 18, 2022 | David C. Benedicto | Chief Financial Officer | Sell | $2K (3,603 @ $0.61) |
| Mar 18, 2022 | Ronald B. Moss | Chief Medical Officer | Sell | $5K (8,199 @ $0.60) |
| Dec 1, 2021 | Ronald B. Moss | Chief Medical Officer | Sell | $28K (35,553 @ $0.79) |
| Dec 1, 2021 | Dennis J Phd Carlo | President & CEO | Sell | $38K (47,870 @ $0.79) |
| Dec 1, 2021 | David C. Benedicto | Chief Financial Officer | Sell | $11K (13,554 @ $0.79) |
| Dec 1, 2021 | David J. Marguglio | SVP and Chief Business Officer | Sell | $40K (50,757 @ $0.79) |
| Nov 20, 2020 | David J. Marguglio | SVP and Chief Business Officer | Sell | $14K (35,000 @ $0.40) |
| Nov 20, 2020 | Robert O Hopkins | Chief Financial Officer | Sell | $14K (35,000 @ $0.41) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.